Evidence map›Paper›PMID 35117963›Full record

ReviewTranslational cancer research2020

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients.

Ignacio Morales-Orue, Juan Zafra-Martin, Laura Garcia, Rodolfo Chicas-Sett, Juan Castilla-Martinez, Maria Auxiliadora Cabezon, Javier Burgos, Marta Lloret, Pedro C Lara

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ignacio Morales-OrueDepartment of Radiation Oncology, Punta de Europa Hospital, Algeciras, Spain.
Juan Zafra-MartinDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Laura GarciaDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Rodolfo Chicas-SettDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Juan Castilla-MartinezDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Maria Auxiliadora CabezonDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Javier BurgosDepartment of Oncology, San Roque University Hospital, Las Palmas de Gran Canaria, Spain.
Marta LloretDepartment of Radiation Oncology, Dr. Negrin University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Pedro C LaraDepartment of Oncology, San Roque University Hospital, Las Palmas de Gran Canaria, Spain.
Hospital Universitario de Gran Canaria Doctor Negrín · ESUniversidad de Las Palmas de Gran Canaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.

Indexed as

breastelderlyoligometastaticradiotherapyStereotactic ablative radiotherapy (SABR)

Identifiers

PMID35117963
PMCPMC8797947
OpenAlexW2973661826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.